Here's what we'll cover Here's what we'll cover Here's what we'll cover Glucagon-like peptide-1 (GLP-1) receptor agonists have emerged as highly effective treatments for a variety of conditions including type 2 diabetes and obesity
Abruptly discontinuing the medication without guidance could lead to a rise in blood sugar levels or other complications
Yuan H, Perry CN, Huang C, Iwai-Kanai E, Carreira RS, Glembotski CC et al
Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality and are only prescribed when determined appropriate by a qualified healthcare provider
Published: Oct 11, 2025 Written by Klarity Editorial Team Published: Oct 11, 2025 Losing insurance coverage for your GLP-1 medication can feel like hitting a wall